EuroMEEting

26th Annual
EuroMeeting
V i e n n a 2014
NEW IN 2014! FLEXIBLE EXHIBITING OPPORTUNITIES
25-27 March 2014
ACV, Vienna, Austria
EXHIBITOR PROSPECTUS
2
Introduction
TABLE OF CONTENTS
Introduction................................................. 2
Preliminary Floor Plan.............................. 3
Attendee Demographics
At-A-Glance................................................. 4
Key Decision Makers &
Exhibiting Companies at
the DIA Euromeeting 2012-2013....... 5-7
About the DIA
Euromeeting 2014 Exhibition.............8-9
Exposure Opportunities......................... 10
EuroMeeting 2014 Exhibitor List...........11
Application Form & Contract...........12-13
SHOWCASE YOUR PRODUCTS AND SERVICES TO KEY DECISION-MAKERS
Connect with pharmaceutical, medical device and related companies as they showcase
the hottest products that foster innovation to improve health and well-being worldwide.
WHY EXHIBIT AT THE DIA EUROMEETING?
DIA’s Annual EuroMeeting brings together more than 3,000 biopharmaceutical, contract service organisation, academic research centre,
and regulatory affairs professionals from more than 50 countries - making it Europe’s largest and most respected industry event. DIA
Europe’s annual flagship event offers timely and relevant session topics, continuing education, networking opportunities, and access to one
of the largest exhibition floors in Europe.
THE EVENT FEATURES

More than 100 sessions in 16 parallel themes, plus stand-alone sessions

350+ speakers, including representatives from the EMA, European Commission, FDA, and European national regulatory agencies

13 Pre-conference tutorials

Student and professional posters

A whole range of networking events - at no additional cost

More than 170 exhibiting companies

Student and young professional events

Hot Topic Sessions

Patient Fellowship Programme
“The biggest event in Europe with attractive
networking opportunities”
HIGHLIGHTS OF THE DIA EUROMEETING EXHIBITION

Anticipated EuroMeeting attendance of more than 3,000

Join more than 170 exhibitors to connect with attendees from more than 50 countries

Explore the latest technologies and services, all under one roof

Exhibition Hall of over 7000 m2
All refreshment breaks, coffee
breaks and lunches, as well as
the Tuesday evening networking
reception will be held in the exhibit
hall, allowing plenty of interaction
between attendees and exhibitors.
Preliminary Floor Plan
Floor Plan layout is subject to change.
3
Switzerland
Demographics at the DIA
EuroMeeting
France
4
Belgium
5%
7%
4%
3%
9%
9%
Netherlands
2%
2%
2% 1%
1%
1%
1% 1%
1%
1% 1%
5%
11%
18%
17%
Sweden
2013 ATTENDEE DEMOGRAPHICS BY REGION
Turkey
18 % Denmark

Italy
 17 % United Kingdom
11 % Germany

Japan
9 % United States

9 % Switzerland

Norway
7 % France

5 % Belgium

Finland
4 % Netherlands

3 % Sweden

 2 % Turkey
2 % Italy

2 % Japan

1 % Norway

1 % Finland

1 % Spain

1 % Poland

1 % Austria

 1 % Ireland
1 % China

1 % Republic Of Korea 
5 % Other

Spain
Poland
Austria
2013
ATTENDEE WORK SETTING
Ireland
 9% Government
China
 80% Industry
Korea,  9% Academia
Republic Of
Other
 2% Student
2013 ATTENDEE LEVELS OF RESPONSIBILITY
 3% CEO, President
 24% Director
 7% Vice President
 11% Senior Level Executive
 24% Manager
 31% Other
Decision makers are eager to hear about your organisation’s products and services!
Our focused environment allows you to have an interactive exchange with more than 3,000 medicines development
professionals, and most importantly, gives you the opportunity to meet key decision makers. Join over 170 exhibitors to interact
with professionals from more than 50 countries in pharmaceutical, devices, government, academia, healthcare delivery and
related industries and with representatives from patient organisations.
5
At the last DIA EuroMeeting, exhibitors met key decision makers, including:
• Chief Executive Officer
• Director Regulatory Affairs
• Global Head, Development and Regulatory Policy
• Chief Medical Officer
• Director, Biomarkers Consortium
• Chief Operating Officer
• Director, Biostatistics
• Global Head, Safety Risk Detection and
Management, Drug Safety and Epidemiology
• Chief Quality Officer
• Director, Clinical Data Management
• Global Regulatory Director
• Chief Specialist, Biometrics Division
• Director, Clinical Operations
• Head Biometrics
• Chief Technical Officer
• Director, Clinical Research Administration Program
• Head Clinical Research Unit
• Senior Vice President Global Integrity
Management
• Director, Drug Evaluation Agency
• Head Medical Governance and Bioethics
• Director, Drug Safety
• Head of Paediatric Medicines
• Clinical Operations Director
• Director, Epidemiology
• Head of Advocacy
• Clinical Outsourcing Leader
• Clinical Pharmacologist
• Director, General Practice Research Database
Division
• Head of Biostatistics and Special
Pharmacokinetics
• Clinical Project Manager
• Director, Global Clinical Resourcing
• Head of Clinical Data Management
• Clinical Quality Assurance Manager
• Clinical Research Director
• Director, Global Quality and Regulatory
Compliance
• Head of Clinical Innovation, Worldwide Research
and Development
• Clinical Safety Team Leader
• Director, Head of Project Management
• Head of Clinical Operations
• Clinical Trial Manager
• Director, International Government Affairs
• Head of Clinical Risk Management
• Compliance & Process Manager
• Director, Licensing Division
• Head of Clinical Safety and Signal Detection
• Compliance Senior Manager
• Director, Pharmacovigilance Advocacy and Policy
• Head of Division Licensing
• Department Director
• Director, Post-Licensing Division
• Deputy Director
• Director, Product Management
• Head of Division: Medicines Assessment and
Clinical Trials
• Deputy Head Global Product Development
• Director, Quality and Regulatory Policy
• Deputy Head of Therapeutic Products Law Section
• Director, Safety Operations, Global Safety
• Director & Senior Regulatory Affairs Consultant
• Drug Safety Manager
• Director Biologics and Biopharma
• eClinical Interface Specialist
• Director Business Development
• Executive Director
• Director Clinical Development
• Executive Director QPPV
• Director Clinical Innovations
• Executive Director, Drugs and Biologics
• Director Clinical Operations
• Executive Director, Worldwide Regulatory
Strategy
• Director Faculty of Pharmacy
• Director for Regulatory Affairs
• Director Global Safety
• Director Global Project Operations
• Director Global Regulatory Affairs
• Director Health Technology Assessment Unit
• Director HTA Policy, Europe & Canada
• Director Market Access
• Director of Bioinformatics
• Director of Business Development
• Director of Business Development, Life Sciences
• Director of General Medicine
• Director of Medical Writing
• Director of National Center of Information
• Head of Orphan Medicines
• Manager Clinical Quality Assurance
• Professor of Clinical Pharmacology
• Professor of Pharmaceutical Technology
• Senior Biomedical Informatics Scientist
• Senior Biostatiscian
• Senior Clinical Disclosure Professional
• Senior Clinical Scientist
• Senior Data manager
• Executive Medical Director
• Senior Project Manager
• Executive Vice President, Oncology
• Senior Quality Risk Specialist
• Global Brand Manager Neuroscience- Emerging
Brands
• Senior Research Leader
• Global Clinical Auditor
• Senior Validation Expert/Lead Auditor
• Global Clinical Operations Head
• Worldwide Deputy Executive Director
• Global Contract Manager
• Worldwide Director, Finance
• Global Director of Regulatory Medical Strategy
• Worldwide Director, Information Technology
• Global Director, Sales and Marketing
• Global Head CQA Computerized System Services
• Global Head Data Management
• Global Head of Medical Writing
• Global Head of Molecular Toxicology
• Director of Research & Development
• Global Head Regulatory Affairs & Quality
• Management
• Director Project Development
• Global Head Safety Science Mature Products
• Director Project Management Clinical
Pharmacology Unit
• Global Head Submission & Registration
Management
• Director Quality Assurance
• Global Head, Development and Marketing
• Senior Statistician
6
Exhibiting Companies at the 2012 and 2013 EuroMeeting
Accenture Life Sciences
ClinTec International
INFOTEHNA Group LLC
Across Systems GmbH
CLS Communication
Innovative Medicines Initiative (IMI)
Acurian
CMIC HOLDINGS Co., Ltd
Innovus/i3
Adamas Consulting Limited
Cognizant
InPharm
Advanced Regulatory/Advanced Search
comply services
Insight Medical Writing
Advanced Search & Selection / Advanced
Regulatory
CoreLab Partners, Inc.
Integrated Clinical Systems, Inc.
Covance
INTERLAB central lab services - Worldwide
AdWare Research Ltd
CRF Health
IntraLinks
AKOS Ltd
CROMSOURCE
invivodata, Inc.
Almac
CROS NT
Just Pharma
AMEDON GmbH
CROss ALLIANCE
Keypeople Ltd
APCER Pharmaceuticals (Europe) Ltd
Crown CRO
Keypoint Consultoria Cientifica
Applied Clinical Trials
CSC Life Sciences
Kinapse Ltd
Aptiv Solutions
CTC Life Sciences
Aris Global
dabl Ltd
KoNECT (Korea National Enterprise for
Clinical Trials)
Arithmos
Datapharm Australia P/L
Lambda-Plus
Arriello s.r.o.
DATATRAK International
Larix A/S
Asia Global Research Co. Ltd
DHI
LA-SER
ASPHALION S.L.
Diamond Pharma Services
Levy Associates
Averion International
Dora Wirth (Languages) Ltd
Lindeq AS
AXESS Ltd.
Drug Safety Alliance, Inc.
Lionbridge Life Sciences
AXPHARMA SAS
DSG, Inc.
Liquent, Inc.
Barrington James Ltd
eClinica
LKF Central Lab
BaseCon
ECLINSO AG
LORENZ Life Sciences Group
Bilcare GCS Ltd
ECRON ACUNOVA
MakroCare
BioClinica
emedcareers.com
Mango Solutions
BioKinetic Europe Ltd
ENNOV-Clinsight
Bio-Optronics
Entimo AG
Maribo Medico Sports & Health Science and
Actigraph
Biopeople - Danish Innovation Network for
Health & Life Sciences
ePharmaSolutions
bioskin GmbH
BioStorage Technologies GmbH
Brillance Sp. z o.o.
Business & Decision Life Sciences
C3i Inc.
Cardio Analytics
Cardiocore
Catalent Pharma Solutions
CCRA
CDISC
CEGEDIM Strategic Data
Celerion
CEMO SA
Chiltern
CIT
CK Clinical
ClinAsia Labs Pvt Ltd
Clinical Ink
Clinical Professionals Ltd
Clinical Reference Laboratory
Clinipace Ltd
clinIT AG
ERT
EUDRAC
European Medicines Agency
Eurotrials
EXTEDO
FGK Clinical Research GmbH
FORENAP Pharma
Foresight Group International
GB Pharma Services & Consulting Srl
GCT (Global Clinical Trials)
Geny Research Group, Inc.
GFA
Glemser Technologies
Global Clinical Trials
Harlan Laboratories
Harrison Clinical Research
Hays Pharma
i4i Inc.
IFAPP
Illingworth Research Ltd
IMI/EMTRAIN, University of Vienna
Imperial
INC Research
MD Events Ltd
MDCPartners
MedDRA MSSO
MEDICADEMY
Medical Research Network Ltd
Medicines Evaluation Unit Ltd
Medidata GmbH
Medidata Solutions Worldwide
Meditrial Europe Ltd
MERCK MILLIPORE
MESM
MNX Global Lifesciences Logistics
MonitorForHire.com
Moravia Worldwide
MZD
NDA Group AB
Neox s.r.o
NextDocs
Nhumi
NNIT
NORMA A/S
Nova Languages Services Ltd
Novo Nordisk
nSpire Health
Exhibiting Companies at the 2012 and 2013 EuroMeeting
Ocasa Logistics Solutions
Satellite (Niche CRO Services)
Octagon Research Solutions Ltd
Schlafender Hase GmbH
Omnicare Clinical Research
SCIderm GmbH
OmniComm Europe GmbH
SDL
Online Business Applications
SEC PHARMA
OpenClinica
Sentrx
Optum
SFL-Regulatory Affairs & Scientific Communication Ltd
Oracle Health Sciences
SGS Life Science Services
Oracle Partner Network
Simbec Research Ltd.
Outcome
Small Planet Meetings Ltd.
Paragon Biomedical
Sofus Regulatory Affairs AB
PAREXEL International
Sparta Systems
Pegasystems
SRA International
Perceptive Informatics
Stamford Consultants AG
PFC Pharma Focus Ltd.
Superior Document
Pharma Clinical AG
Swissmedic
Pharmaceutical e-Consulting Ltd
SYMFO International SA
Pharmaceuticals and Medical Devices Agency (PMDA)
Synchrogenix Information Strategies, Inc.
PharmacoSoftware GmbH
SYNE QUA NON
PharmaForms GmbH
Synevo Central Lab
Pharmalink Consulting
Synowledge Drug Safety and Regulatory Affairs Services
Pharmalink Consulting Limited
Synteract, sro
PharmaNet Development Group
TAKE Solutions
PharmaVigilant
Tarius
Pharm-Olam Internaional Ltd
TecHorizon
PHARM-SOFT Dr. B. Rodust GmbH
TechTeam Global
PHASTAR
The Clinical Trial Company Ltd
PhRISMA b.v.
The Regulatory Affairs Company
PHT Corporation
the Uppsala Monitoring Centre
Popewoodhead & Associates Ltd.
The Weinberg Group Inc.
PRA International
Thomson Reuters
Premier Research
TOPRA
PrimeVigilance Ltd
Transcrip Partners LLP
ProClinical Ltd
TransPerfect
ProductLife BVBA
Trifecta Multimedical
PRUDENTAS LLC
Trilogy Writing & Consulting
PSI
United BioSource Corporation
Quadratek Data Solutions Ltd
UNITHINK
Quality & Compliance Consulting, Inc.
Universal Medica
QUMAS
University Hospital Clinical Trial Alliance (UHCT Alliance)
RBW Consulting LLP
Veeva Systems, Inc.
Real Pharma
Viedoc
Real Regulatory
Virtify, Inc
Reed Technology
Vitalograph Ltd.
Regulatory Pharma Net s.r.l.
WCI Consulting Limited
Regulatory Resources Group Ltd
WellCRO (Brand of Axonal)
Regxia Inc.
Wiley-Blackwell
Richmond Pharmacology Ltd.
Wingspan Technology, Inc.
RPS, Inc.
Woodley Equipment Company Ltd
RWS Translations
XAIT
RxLogix
XClinical GmbH
SafetyDrugs
Zenosis
7
About the DIA EuroMeeting 2014 Exhibition
8
BOOTH & PRICING INFORMATION
FLEXIBLE EXHIBITING OPPORTUNITIES
What is included per 3m x 3m booth space
NEW in
2014
€ 4’650.00
• 1 complimentary full-conference registration
• 1 small table
• 3 exhibit booth personnel registrations
• 3 chairs
• Shell scheme walls, white, 2,5m high
• 1 waste basket
• Carpet tiles
• 1 spotlight per 3 meter
• Closed fascia in white
• 2 kw main power supply, incl double wall socket and
consumption for three days
• Company name and stand nr in black on two sides
Any staff required above those allotted per 3m x 3m space must register as additional booth personnel or a normal attendee incurring subsequent fees. Additional expenses
associated with the exhibit, including special booths, lights, phone, additional electrical connections, etc., will be the responsibility of the Exhibitor.
What is included per 3m x 2m booth space
€ 3’500.00
• 1 complimentary full-conference registration
• 1 exhibit booth personnel registration
RESERVE YOUR DIA EUROMEETING
EXHIBITION SPACE TODAY!
• 1 small table
• 2 chairs
• 1 waste basket
• Carpet tiles
• 1 spotlight per 3 meter
• 1 electrical outlet
Any staff required above those allotted per 3m x 2m space must register as additional booth personnel or a normal attendee incurring subsequent fees. Please note that there will
be NO pre-fitted shell scheme provided. Additional expenses associated with the exhibit, including special booths, lights, phone, additional electrical connections, etc., will be the
responsibility of the Exhibitor.
What is included per Tabletop Display
• 1 exhibit booth personnel registration
• 1 table 160cm x 80cm
• 1 chair
• 1 waste basket
€ 2’500.00
For a full-size version of the floor plan
go to www.diahome.org/EM2014
and click on Exhibition
• 1 electrical outlet
Any staff required above those allotted per space must register as additional booth personnel or a normal attendee incurring subsequent fees. Exhibitors may not sublet or share
any part of the space allocated to another company. All display materials must be placed on surface of the table, pop-up tabletop displays may be used. No additional equipment
may be placed in surrounding area, with the exception of floor banners (maximum size of 200 x 80 cm) behind your tabletop if space allows.
Fore more information about exhibiting at the DIA EuroMeeting 2014, contact Roxann Schumacher at
+41 61 225 51 38 or email [email protected]
9
SCHEDULE AT A GLANCE
All refreshment and lunch breaks, as well as the Tuesday and Wednesday receptions will be held in the exhibition hall
allowing plenty of interaction between attendees and exhibitors.
EXHIBITION HALL HOURS
SET-UP
Monday, 24 March 2014............................................................................................................................................................................. 09:00 - 18:00
Tuesday, 25 March 2014............................................................................................................................................................................07:30 - 11:00
SHOW HOURS
Tuesday, 25 March 2014...........................................................................................................................................................12:00 - 19:00
Lunch...............................................................................................................................................................................................................12:00 - 14:00
Refreshment Break...................................................................................................................................................................................... 15:00 - 15:45
Welcome Reception....................................................................................................................................................................................17:30 - 19:00
Wednesday, 26 March 2014....................................................................................................................................................09:00 - 18:30
Refreshment Break...................................................................................................................................................................................... 10:15 - 11:00
Lunch .............................................................................................................................................................................................................12:00 - 14:00
Guest Passes..................................................................................................................................................................................................14:00 - 16:00
Refreshment Break...................................................................................................................................................................................... 15:15 - 16:00
Reception........................................................................................................................................................................................................17:30 - 18:30
Thursday, 27 March 2014........................................................................................................................................................ 09:00 - 16:00
Refreshment Break......................................................................................................................................................................................10:15 - 11:00
Lunch...............................................................................................................................................................................................................12:00 - 14:00
Refreshment Break...................................................................................................................................................................................... 15:15 - 16:00
DISMANTLE
Thursday, 27 March 2014.........................................................................................................................................................................16:00 - 23:00
10
The DIA EuroMeeting 2014 offers the best opportunities to demonstrate key features of your
products and services and increase your company’s exposure
 Traffic-generating activity programme in the Exhibition Hall, including:
•
All refreshment breaks and lunches
•
Tuesday & Wednesday evening receptions for all exhibitors and attendees
•
DIA Booth
•
Attendee Lounge
•
DIA Members Only Lounge
•
Cyber Café / Recharging Station
•
Student and Professional Poster Display Area
•
DIA prize draw to encourage attendees to visit multiple booths
•
Press room
 Expand your visibility beyond the exhibition floor with exciting marketing and hosting opportunities
Hosting Opportunities
•
Tuesday / Wednesday Networking Drinks Reception
•
Private Reception at Booth
•
Juice Bar at Booth
•
Attendee Lounge
•
Refreshment Break and /or Lunch Break
•
Cyber Café / Recharging Station
•
Massage Therapist at Booth
•
Shoe Shine Station at Booth
•
Ice Cream Cart at Booth
•
Company logo on water coolers
•
Delegate bag insert
•
Floor Stickers
•
Company logo on exhibition floor plan located in a high traffic area
•
Display promotional materials in exhibitor kiosks strategically located in high-traffic areas
•
Participate in a bulk mailing delivered to meeting participants approximately two weeks prior to the meeting, to publicise your events
and/or services
•
Advertising in the EuroMeeting final programme and EuroMeeting Extra, both of which are distributed to every attendee
•
EuroMeeting mobile app logo banner
•
Innovation theatre presentation
•
Exhibitor client invite programme
•
Floor Plan Logo
NEW in 2014
NEW in 2014
NEW in 2014
NEW in 2014
NEW in 2014
NEW in 2014
 Meeting Room rental for business development meetings with prospective customers or staff briefing
 Pre-EuroMeeting press release programme
 Listing in the EuroMeeting Final Programme describing your booth location and products
 Lead retrieval system
 Connect with attendees prior to the conference on the DIA Europe LinkedIn group
 Excellent customer service support, resources and marketing ideas to help you get the most value from your exhibit in
the lead up to, and after the EuroMeeting
For more information on hosting opportunities, contact Roxann Schumacher
on +41 61 225 51 38 or email [email protected]
11
EuroMeeting 2014 Exhibitor List as of 5 November 2013
THESE EXHIBITORS HAVE ALREADY SECURED THEIR BOOTH AT THE 26TH ANNUAL EUROMEETING
DON'T MISS OUT, JOIN THEM!
Accenture
United Kingdom
Applied Clinical Trials United States
Aptiv Solutions
United States
ArisGlobal
United Kingdom
Arriello Group
Ireland
AXPHARMA SAS
France
BASECON A/S
Denmark
Cardiocore
United States
CCRA
United Kingdom
CMIC Holdings Co., Ltd
Japan
CTC Clinical Trial Consulting
Switzerland
DATATRAK United States
DIASwitzerland
DIA Patient Fellowship
Switzerland
DIA Student Corner
Switzerland
ERT Inc.
United States
EUDRAC Ltd
United Kingdom
European Medicines Agency
United Kingdom
European Pharminvent Services Ltd
Czech Republic
EurotrialsPortugal
EXTEDO GmbH
Germany
FLEX DATABASES
Russia
Foresight Group International
United States
Insight Medical Writing
United Kingdom
IST GmbH
Germany
Keyrus Biopharma SA
Belgium
Kinapse
United Kingdom
LA-SER ANALYTICA
United Kingdom
LindeqNorway
LIQUENT, A PAREXEL Company
United States
LORENZ Life Sciences Group Germany
MedDRA MSSO United States
MEDICADEMYDenmark
Medidata Solutions Worldwide
United Kingdom
MEDIS Research Group
Germany
Moravia IT as
Czech Republic
NDA Group Sweden
NextDocs
United States
NNIT A/S Denmark
nSpire Health, Inc.
United States
Online Business Applications
United States
PharmaForms / Amedon
Germany
Pharmalink Consulting Ltd
United Kingdom
PHT Corporation
United States
Pope Woodhead and Associates Ltd
United Kingdom
ProductLife Group
France
Proswell Medical Company
China
Quality and Compliance Consulting, Inc. United States
Quintiles
United States
Real Regulatory Limited
Ireland
Regulatory Pharma Net s.r.l.
Italy
RJR Consulting Inc. United States
RWS Group
United Kingdom
SanaClis s.r.o.
Slovakia
Schlafender Hase GmbH
Germany
syneed medidata GmbH
Germany
TariusDenmark
the Uppsala Monitoring Centre
Sweden
Thomson Reuters
United States
TransPerfect
United Kingdom
Trilogy Writing and Consulting GmbH
Germany
United BioSource Corporation United States
Universal Medica
France
Veeva Systems
United Kingdom
ViedocSweden
XClinical GmbH
Germany
YEAR-ROUND EXHIBITING OPPORTUNITIES!
Throughout the year, DIA holds more than 100 meetings, workshops and conferences around the world, many of which offer exhibiting
opportunities. Attendee numbers at DIA events range from 50 - 8,000, so the exhibition programme ranges from a concentrated number of
tabletop exhibits to traditional exhibition hall trade shows. Examples of conferences with exhibition opportunities include:
EUROPE:
CHINA:
INDIA:
•EuroMeeting
•China Annual Meeting
•India Annual Meeting
JAPAN:
LATIN AMERICA:
•Japan Annual Meeting
•Latin American Clinical Congress
•European eDM
•Medical Writing /Medical Information
Conference
•Asian New Drug Development
NORTH AMERICA:
•Japanese CDM
•Annual Meeting
•Cardiac Safety Workshop
•Canadian Annual Meeting
•eDM and eSubmissions
•Marketing Pharmaceuticals
•Medical Communications
•Pharmacovigilance and Risk Management
•Rare Diseases and Orphan Products
For more information contact [email protected]
or visit www.diahome.org
Application & Contract For Exhibit Space
12
26th Annual EuroMeeting
25-27 March 2014 | ACV, Vienna, Austria | ID #14101
Company Contact/Billing Information
Exhibit Space Rates and Information
 3m x 3m Booth Exhibiting Company Name
(for signage and directory listing. Only use capital letters if in the company name)
Contact Name (to which correspondence will be sent)
Address Line 1
€ 4’650.00
Each 3m x 3m space includes one (1) full meeting registration and up to three (3) exhibit
booth personnel registrations. Any staff required above those allotted per 3m x 3m space
must register as additional booth personnel or a normal attendee incurring subsequent
fees. Each booth space includes pre-fitted shell scheme, one (1) table, two (2) chairs,
carpet and one (1) electrical connection. Additional expenses associated with the exhibit,
including special booths, lights, phone, additional electrical connections, etc., will be the
responsibility of the Exhibitor.
 3m x 2m Booth Address Line 2
Postal Code, City (State), Country
Telephone Number
Fax Number
€ 3’500.00
Each 3m x 2m space includes one (1) complimentary full meeting registration and one (1)
exhibit booth personnel registration. Any staff required above those allotted per 3m x 2m
must register as additional booth personnel or a normal attendee incurring subsequent
fees. Each booth space includes one (1) table, two (2) chairs and one (1) electrical
connection and carpet. Please note that there will be NO pre-fitted shell scheme provided.
Any additional expenses associated with the exhibit, including pop up stand, lights, phone,
additional electrical connections, etc., will be the responsibility of the exhibitor.
 Tabletop Display
Email Address (required for confirmation)
Please provide your European VAT number
Payment Options and Information
Payment may be made by cheque, credit card, or bank transfer. Please note that exhibit space
will not be assigned without payment in full. Companies with an outstanding balance will be
prohibited from moving in at the ACV, Vienna.
€ 2’500.00
Each space includes one exhibit booth personnel badge . Any staff required above those
allotted per space must register as additional booth personnel or a normal attendee
incurring subsequent fees. Tabletop display cost includes one table and one chair.
Exhibitors may not sublet or share any part of the space allocated to another company.
Only one 160 x 80 cm table, chair and electrical outlet will be provided per table. All display
materials must be placed on surface of the table, pop-up tabletop displays may be used.
No additional equipment may be placed in surrounding area, with the exception of floor
banners (maximum size of 200 x 80 cm) behind your tabletop if space allows.
Number of Booths/Tabletop Displays requested: Total Amount Due:
____________________
€
____________________
Credit card payment is preferred
 Credit card payments by Visa, MasterCard, or American Express can be
made by completing the relevant information below.
 Visa
 MC
 AMEX
Expiration date: __________
Credit Card Number
The booth selection schedule is based on the date and time your paid application is received
at DIA Europe. Booth number requests will not be considered until DIA Europe has notified
you of your turn to select. Your selection “rank” will be included in your confirmation email.
Services/Products to be exhibited:
Cancellation and Downsizing Policy
Name as it appears on credit card
All Cancellations/Downsizing requests MUST be made in writing.
• Cancellations/Downsizing requests received on or before 25 November 2013
will receive a 75% refund;
Signature
• Cancellations/Downsizing requests received on or before 24 January 2014 will
receive a 50% refund;
 Cheques should be made payable to: DIA with a copy of the application form to facilitate
identification to:
DIA Europe, Kuechengasse 16, Postfach, 4002 Basel, Switzerland
 Bank transfers in EURO should be made to:
Account Holder: Bank: IBAN: DIA Europe Account Number: SWIFT Code:
DIA
UBS, Postfach, CH-4002 Basel, Switzerland
CH96 0023 3233 6353 8460C
233-635384.60C
UBSWCHZH80A
The company name, as well as the Meeting ID#14101, must be included on the transfer
document to ensure payment to your account.
Please email or fax this form prior to payment. Payment does not denote approval of your
application to exhibit. If application is denied a full refund will be processed. Payments must
be net of all charges and bank charges must be borne by the payer.
• Cancellations/Downsizing requests received after 24 January 2014 will
receive NO refund. Booth rental fees are non-transferable.
Contract Signature
The undersigned hereby authorises DIA Europe to reserve exhibit space in the ACV, Vienna,
Austria, for use by the above company or organisation during DIA Europe’s 26th Annual
EuroMeeting. The undersigned hereby acknowledges receipt of and agrees to abide by the
terms and conditions of the contract and Rules and Regulations contained on the reverse
side of this application. DIA Europe reserves the right in its sole and absolute discretion to
reject any application that in its judgment does not enhance the purpose of the 26th Annual
EuroMeeting & Exhibition or is in direct competition with DIA Europe. This contract shall
be deemed accepted by DIA Europe when received together with the required payment.
However, no contract shall be deemed accepted if the contracting Exhibitor has outstanding
financial obligations to DIA Europe, of which DIA Europe is aware, for booth space, advertising,
or any service(s) provided by DIA Europe.
Authorised SignatureDate
Completed applications should be emailed to Roxann Schumacher, DIA Europe, Exhibits Department
Telephone +41 61 225 51 38 or email: [email protected] or faxed to +41 61 225 51 52
Application & Contract for Exhibition Space
Rules and Regulations
This contract along with the Exhibitor Policies and Procedures for Exhibitors booklet, which is furnished to each exhibiting company in
advance of the show, contains the entire agreement between the exhibiting company (“Exhibitor”) and the Drug Information Association.
The 26th Annual EuroMeeting to be held at the Austria Center Vienna (ACV), Vienna Austria, is managed by DIA Europe.
1. Eligible Exhibits: DIA Europe reserves the right to determine eligibility of any
company or product to participate in the show. DIA Europe can refuse rental of
exhibit space or terminate this contract if already executed, to any company who
is in direct competition with DIA Europe or whose display of goods and/or services
is not in DIA Europe’s sole judgment, compatible with and complementary to the
show and the industry, which DIA Europe serves. In the event of such termination,
DIA Europe shall refund, in full, all payments, including deposits, which it may
have received from the Exhibitor.
2. Booth Assignments: Will be made based upon the date the Application &
Contract for Exhibit Space is received, as well as the booth selection, booth size,
location specifications and proximity to other companies as indicated by the
Exhibitor. Furthermore, in the judgment of DIA Europe, if it becomes necessary to
change the original allocation of space, the DIA Europe may do so by notification
to the Exhibitor’s authorised representative.
3. Exhibit Space Rental Fee: The DIA Europe exhibit space rental fees are outlined
on the front of this Application & Contract for Exhibit Space.
4. Payment: The payment schedule is outlined on the front of this Application &
Contract. The entire exhibit space rental fee will accompany this Application &
Contract. No Exhibitor will be allowed to participate in the show unless payment
in full is received prior to the start of the exposition. DIA Europe complies fully
with the VAT regulations of the country where the exhibition is held.
5. Cancellations: Exhibitors have the right to cancel their space reservations at
any time by written notice to DIA Europe. Refunds will be issued based on the
total amount paid and the date the notice of cancellation is received. A nonrefundable fee will be withheld from the amount refunded to cover administrative
costs. Registrants are responsible for cancelling their own hotel and airline
reservations. Under all circumstances, DIA Europe retains the right to resell any
booth space cancelled by the Exhibitor. Refunds will be based on when the notice
of cancellation is received. The use of any complimentary Exhibitor registration
badges is forfeited upon cancellation of space.
6. Use of Space: No subletting or sharing of space is permitted. DIA Europe retains
the right to have removed from the exhibition any company that has not duly
contracted with DIA Europe for space. All Exhibitor activities must be confined
to the limits of rented space and must not impede traffic or interfere with the
activity of other Exhibitors. Every exhibit must be fully staffed and operational
during the entire show. DIA Europe may evict Exhibitors, who, because of noise,
conduct of personnel, methods of operation or any other reason, detract from the
general educational character of the show. In the event of eviction, DIA Europe
will not issue a refund.
7. Failure to Occupy Space: Any space not at least partially occupied at least
30 minutes prior to opening, will be forfeited by the Exhibitor and can be used
by DIA Europe in any manner, without refund, unless arrangements for delayed
occupancy have been previously approved by DIA Europe. All booths must be
set-up and ready for the show by the walk through inspection.
8. Character of Exhibits: DIA Europe provides aisle carpeting in main and cross
aisles and general security in the exposition beginning with Exhibitor set-up
and concluding after all show freight has been removed from the floor. All stand
structures must adhere to the guidelines laid out in the Exhibitor Services Kit for
this exhibition. No exhibit is permitted to obstruct the view of adjacent booths.
All signs must be one sided only and must be set back within the Exhibitor’s
space so as not to detract from the overall impact of the exhibit that is directly
adjacent. Requests to deviate from these guidelines must be submitted in writing
to DIA Europe for approval prior to set-up. DIA Europe reserves the right to direct
revisions, at Exhibitor expense, of any exhibit that does not comply with these
guidelines. Apart from the specific display space for which an exhibiting company
has contracted with DIA Europe, no part of the ACV its grounds or surrounding
grounds, may be used by any organisation other than DIA Europe for display
purposes of any kind or nature without the express written permission of DIA
Europe. Exhibit brand or company logos, signs and/or trademark displays will be
limited to the exposition only.
9. Fire Regulations: Each Exhibitor is responsible for knowledge of and adherence
to all Amsterdam fire and safety codes which will be published in the Exhibitor
Service Kit. All electrical signs and equipment must be wired to meet the
specification of Underwriters Laboratories (UL) and must conform to appropriate
federal, state, and municipal codes. Compliance with such laws is mandatory for
all Exhibitors and is the sole responsibility of the Exhibitor.
10. Indemnity: The Exhibitor agrees to indemnify and hold harmless the DIA
Europe, its officers, directors, employees and members from any and all liability
to any person or persons for or by reason of any condition, defect or operation
of any apparatus, equipment, or fixtures furnished by the Exhibitor in connection
with his/her exhibit. Exhibitor further agrees to hold harmless the DIA Europe,
its officers, directors, employees and members from any and all liability to any
person or persons for or by reason of any act or omission of said Exhibitor, or
any of his/her agents, servants or employees. This Indemnity includes, but is not
limited to, claims of injury, death, or property damage, or of copyright, trademark
or patent infringement, unfair competition, and product liability. The Exhibitor,
on signing the contract, expressly releases the DIA Europe and it’s individuals
from any and all claims for such loss, damage or injury. Exhibitor assumes entire
responsibility and hereby agrees to protect, indemnify, defend and hold the DIA
Europe, its officers, directors, employees and members, and the meeting facility
and its employees and agents harmless against all claims, losses and damages
to persons or property, governmental charges, taxes or fines, and attorneys’
fees arising out of or caused by Exhibitor’s installation, removal, maintenance,
occupancy or use of the exhibition premises or part thereof, excluding only such
liability caused by the sole negligence of the meeting facility, its employees and
agents. In addition, Exhibitor acknowledges that the DIA Europe and the meeting
facility do not maintain insurance covering such losses by Exhibitor.
11. Exhibitor Insurance: The Exhibitor shall, at its sole cost and expense, procure
and maintain through the term of each contract, comprehensive general liability
insurance against claims for bodily injury or death and property damage occurring
in or upon or resulting from the premises leased by DIA Europe. Such insurance
shall include contractual liability and product liability coverage, with combined
single limits of liability of not less than €1,000,000. Such insurance shall name
DIA Europe as an additional insured and Exhibitor shall upon request provide
DIA Europe with certificate so indicating. Workers Compensation and any other
insurance or required licenses shall be in full compliance with all federal and state
laws, covering all of Exhibitor’s employees engaged in the performance of any
work for the Exhibitor. All property of the Exhibitor is understood to remain under
its custody and control in transit to and from the confines of the exhibit hall.
12. Show Attendees and Exhibit Staff: Admission to the exhibition will be available
only to registered attendees and Exhibitor staff of at least 18 years of age. Proof
of age may be required to obtain entrance into the exposition. DIA Europe makes
reasonable attempts to attract high quality attendees to its exposition, but does
not guarantee specific volumes of traffic or levels of qualification. Traffic at any
given booth is a function of the particular exhibit and not the responsibility of
DIA Europe.
13. Security: Exhibitors are responsible for security of their exhibit and its content.
Security personnel contracted directly by DIA Europe are intended primarily for
crowd control and credentials verification. Exhibitors are encouraged to budget
and make security arrangements for sensitive or valuable items. DIA Europe is
not responsible for the security of Exhibitors’ property. Protection, both security
and insurance coverage, of Exhibitors’ property is the sole responsibility of the
Exhibitor.
14. Failure to Hold Show: Should fire, hurricane, earthquake, flood, strikes, civil
disturbance, Acts of God, political or social boycott, or any other circumstances
beyond the control of the DIA Europe or the AVC make it impossible or impractical
to hold the show at the scheduled time, DIA Europe may retain only such part of
the Exhibitor’s rental fees as shall be required to compensate it for reasonable
expenses incurred up to the time of such cancellation. All remaining rental fees
shall be refunded. If an event is cancelled, DIA Europe is not responsible for any
airfare, hotel or other costs incurred by registrants. In no event shall DIA Europe
be liable for indirect or consequential damages.
15. Amendment of Rules: DIA Europe reserves the right to make changes,
amendments and additions to these terms and conditions at any time, and all
changes, amendments and additions so made shall be binding on the Exhibitor
with the provision that all Exhibitors will be advised of any such changes. Any
matters not specifically covered herein are subject to decision by DIA Europe.